1. Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds — Alnylam posts positive results of groundbreaking phase 3 PH1 trial — FDA expands probe into safety of AstraZeneca's COVID vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

What would the pharmaceutical industy look like under a Cruz presidency?

Discussion in 'The Politics of Healthcare' started by mbryan, Feb 29, 2016 at 12:02 PM.

  1. mbryan

    mbryan Administrator
    Staff Member

    Jul 19, 2015
    Likes Received:
    What would a President Cruz do to pharma?

  2. anonymous

    anonymous Guest

    A Cruz presidency would go a long way to reviving the glory days of pharma. I think he would pare back useless and outright harmful over-regulation. As a result we would see more innovation more
    Choices and lower prices with improved care.

    Frankly I believe the FDA's sole mandate should be safety. Efficacy is something the market can and
    Would sort out. I would hope that promotional
    Regulations would be pared back. As recent
    Court Cases have proven, the FDA has overstepped
    It's bounds in restricting the speech and promotional efforts of companies and their representatives.
  3. anonymous

    anonymous Guest

    Who cares? He’ll never be president.